Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01590017
What this trial is testing

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

Who this might be right for
Cervical CancerAcquired Immunodeficiency Syndrome
AIDS Malignancy Consortium 41
Large-scale testing (Phase 3)UnknownNCT02484040
What this trial is testing

Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer

Who this might be right for
Response to ToxinToxicityRecurrence
Jong Hoon Lee 370
Not applicableLooking for participantsNCT07510724
What this trial is testing

Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab

Who this might be right for
Small Cell Lung Cancer (SCLC)Non-Small Cell Lung Cancer (NSCLC)Lung Cancer (Diagnosis)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 240
Testing effectiveness (Phase 2)Looking for participantsNCT07362979
What this trial is testing

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 243
Testing effectiveness (Phase 2)Study completedNCT01362296
What this trial is testing

An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 134
Not applicableStudy completedNCT01671683
What this trial is testing

Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Chungnam National University 44
Early research (Phase 1)Study completedNCT00513383
What this trial is testing

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Massachusetts General Hospital 34
Large-scale testing (Phase 3)UnknownNCT00486460
What this trial is testing

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tel-Aviv Sourasky Medical Center
Testing effectiveness (Phase 2)UnknownNCT04238988
What this trial is testing

Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

Who this might be right for
Locally Advanced Cervical Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 45
Early research (Phase 1)Looking for participantsNCT06713369
What this trial is testing

AZD5305 hADME in Patients With Advanced Solid Malignancies

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
AstraZeneca 8
Large-scale testing (Phase 3)Study completedNCT01812369
What this trial is testing

Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
University Hospital, Rouen 500
Early research (Phase 1)Study completedNCT01207323
What this trial is testing

The Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors

Who this might be right for
Epithelial Tumors, Malignant
Genentech, Inc. 66
Testing effectiveness (Phase 2)Ended earlyNCT01425996
What this trial is testing

A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Taiwan Liposome Company 3
Testing effectiveness (Phase 2)Study completedNCT00682383
What this trial is testing

Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Unresectable Locally Advanced NSCLC
Mt. Sinai Medical Center, Miami 26
Large-scale testing (Phase 3)Looking for participantsNCT07461454
What this trial is testing

YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced or Metastatic Breast Cancer
MediLink Therapeutics (Suzhou) Co., Ltd. 376
Post-approval studies (Phase 4)Study completedNCT01230710
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 51
Testing effectiveness (Phase 2)Study completedNCT00875979
What this trial is testing

Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 67
Early research (Phase 1)Study completedNCT03489369
What this trial is testing

Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas

Who this might be right for
Metastatic CancerSolid TumorLymphoma
Symphogen A/S 15
Testing effectiveness (Phase 2)UnknownNCT05898373
What this trial is testing

Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC

Who this might be right for
Salivary Gland Cancer
Peking Union Medical College 120
Testing effectiveness (Phase 2)Study completedNCT00005086
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer

Who this might be right for
Bladder Cancer
University of Chicago 6
Next Page